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Outcomes of carotid endarterectomy: How does
the Australian state of New South Wales compare
with international benchmarks?
Sandy Middleton, MN, and Neil Donnelly, MPH, Sydney, New South Wales, Australia
Objectives: The objective of this study was to determine the outcomes of carotid endarterectomy (CEA) in New South
Wales, Australia.
Methods: This state-wide prospective audit of all public and private hospitals during a 6-month period had main outcome
measures of 30-day mortality, 30-day fatal stroke, 30-day nonfatal stroke, and 30-day combined stroke and mortality.
Results: Fifty-three of 54 eligible surgeons participated (response rate, 98%). The audit obtained inpatient data for 689
internal CEA procedures performed on 666 patients. Of 666 first or only procedures, 462 (69.4%) were performed on
patients who were symptomatic and 204 (30.6%) on patients who were asymptomatic. After adjustment for cluster by
surgeon, we determined a state-wide 30-day death rate of 1.2% (95% CI, 0.3% to 2.1%), a 30-day fatal or nonfatal stroke
rate of 3.0% (95% CI, 1.6% to 4.4%; ipsilateral stroke, 2.6%), a 30-day nonfatal stroke rate of 2.3% (95% CI, 1.1% to 3.4%;
ipsilateral stroke, 2.0%), and a 30-day combined stroke and death rate of 3.5% (95% CI, 2.1% to 4.9%). A significant linear
relationship was found between patient preoperative hypertensive status and the combined 30-day stroke and death rate
(trend odds ratio, 3.5; 95% CI, 1.6 to 7.7). No association was seen between any main outcome measures and hospital
volume (<10 CEAs versus >10 CEAs). Four patients underwent surgery outside guideline recommendations (CEA
performed for either <30% stenosis or occluded carotid artery).
Conclusion: This first comprehensive state-wide audit confirms that Australian surgeons achieve 30-day outcomes
comparable with international benchmarks. (J Vasc Surg 2002;36:62-9.)
Two seminal initiatives in Australia sought to enhance
stroke prevention and management: the “National Stroke
Strategy” published by the National Stroke Foundation1
and the National Health and Medical Research Council
“Clinical Practice Guidelines for the Prevention of
Stroke.”2 A Stroke Expert Working Group was established
to further promote these policies.3 Impetus for these initi-
atives resulted, in part, from publication of large studies
that showed significant improvements in stroke outcomes
from vascular surgery.4-7 Level I evidence (metaanalysis of
two trials) exists for the effectiveness of carotid endarterec-
tomy (CEA) in reduction of disabling stroke and death
rates for patients who are symptomatic with 50% carotid
artery stenosis ipsilateral to a recent carotid territory isch-
emic event.8 Level I evidence (metaanalysis of four trials)
also exists for the effectiveness of CEA in the reduction of
stroke rate for patients who are asymptomatic.9
Hospitals, centers, surgeons, and patients who partici-
pated in trials that contributed to these metaanalyses were
highly selected, however. Eligibility for participation in the
North American Symptomatic Carotid Endarterectomy
Trial (NASCET) required centers to have 30-day stroke
and death rates of less than 6%.10 Participation in the
Asymptomatic Carotid Atherosclerosis Study (ACAS) re-
quired surgeons to have stroke and death rates of less than
3% for patients who were asymptomatic and less than 5% for
patients who were symptomatic.11 As a result, less than 4%
of all potential American institutions were selected for
participation in either NASCET or ACAS.12
Patients also were selected with strict eligibility criteria.
A study that compared the mortality rates for patients from
American hospitals in NASCET and ACAS (“trial” hospi-
tals) with patients from other institutions that performed
CEA (“nontrial” hospitals) found the mortality rate for
patients who underwent the procedure at a trial hospital
was higher (1.4%) than that reported in either NASCET
(0.6%) or ACAS (0.4%).12
Whether outcomes can be achieved in routine practice
outside the strict conditions of surgical research is largely
unknown. Only one state-wide audit of CEA practices
within Australia ever has been published, with an overall
inhospital stroke and death rate for 239 CEA procedures of
5.9%.13 Stroke and death rates for the 11 participating
surgeons varied from 0% to 14%.13
Yet demand is increasing for better information about
the performance of the health system.14 Although random-
ized trials generate evidence for identification of best treat-
ments, they are not designed to monitor routine practice.15
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Given the importance of stroke prevention and manage-
ment as a global health priority,1,2 we report a prospective
state-wide audit in New South Wales (NSW).
METHOD
Audit protocol. A multidisciplinary Project Working
Group (PWG) was established to oversee the audit and
included 31 surgeons, 11 neurologists, and three neurosur-
geons (Appendix). Ethics approval was obtained from Cen-
tral Sydney Area Health Service Ethics Review Committee.
For determination of which items to include on the
audit data forms, 44 peer-reviewed studies of CEA pub-
lished from 1983 to 1997 were examined, generating 56
potential measures of process and a further 28 potential
measures of outcome.16 The PWG was asked to indicate
whether each measure was “essential” or “optional” for
inclusion in the audit. After collation of responses and
discussion, the PWG achieved consensus to measure 36
process variables and four major outcome variables.
Two standard audit data forms then were developed.
The Inpatient Audit Data Form documented patient details
(seven items), history (six items), assessment (four items),
investigations (seven items), complications of angiography
(two items), surgical details (nine items), and outcomes on
discharge from hospital (13 items). The second form, the
30-Day Audit Data Form, was designed for completion 30
days after surgery. This time period was chosen for com-
parison of results with published metaanalyses.8,9 The 30-
Day Audit Data Form was divided into six sections: patient
details (six items), death within 30 days (four items), new
neurologic event (seven items), other complications (three
items), assessment (two items), and discharge (six items).
Twelve clinicians provided independent peer review for our
final audit protocol and forms. Both audit data forms are
available on written request.
The Royal Australasian College of Surgeons gave ap-
proved recognition of the audit. With participation, Fel-
lows met the College’s requirements for surgical audit as
part of its Continuing Medical Education and Recertifica-
tion Programme.17
Surgeon recruitment. Names of members of the
Australian and New Zealand Society for Vascular Surgery
who practiced in NSW were obtained (n  58). Lists of
vascular surgeons (n 8) and cardiothoracic surgeons (n
39) also were purchased from a commercial mailing house.
In addition, five neurosurgeons were identified by PWG
members. Duplicates were deleted for identification of all
potentially eligible surgeons (n  90). All surgeons were
contacted by S.M. to ascertain performance of CEAs.
Those surgeons who did not perform CEAs were excluded
from the audit (n  36). The remaining 54 surgeons were
sent letters of invitation to participate. Because less than
1.5% of CEAs in Australia are performed by general sur-
geons, we recruited only vascular surgeons and neurosur-
geons.18
Data collection. Surgeons were asked to participate
for a minimum period of 6 months, commencing May 1,
1999, unless otherwise negotiated. Data collection ceased
on December 31, 1999. Although the PWG acknowledged
that diagnosis of postoperative stroke would have been
more sensitive if assessed independently by a neurologist,19
surgeons were not required to have their patients so re-
viewed unless this was usual clinical practice.
Eligible patients were those who underwent a left or
right internal or external CEA for the first time. Patients
were excluded from the audit by the PWG if the operation
was either a “redo” on an internal carotid artery or CEA
performed with the same anesthetic as cardiothoracic sur-
gery. Patients who underwent external CEA also were
excluded from analyses.
Data analysis. Data were analyzed with SPSS (Ver-
sion 9.0; SPSS Inc, Chicago, Ill).20 We confined our out-
come analysis to those patients who underwent their first or
only CEA during the audit period. All analyses also were
adjusted for clustering of patients within surgeons.21 Intra-
cluster correlations and 95% CIs around proportions were
calculated with STATA (Version 5.0; Stata Corporation,
College Station, Tex)22 for each of the four 30-day post-
operative outcomes (namely death, fatal stroke, nonfatal
stroke, and combined stroke and death). Binomial gener-
alized estimating equations were used to estimate odds
ratios (ORs) and associated CIs for both unadjusted and
adjusted associations of predictor variables for each out-
come.23
For all reported ORs comparing patients who were
symptomatic and asymptomatic, the former serve as the
referent group. Hypothesized or previously shown predic-
tors of stroke and death after CEA were examined. ORs also
were determined for stroke and death and type of hospital
(private, principal referral, major metropolitan, and major
nonmetropolitan), in addition to surgeon volume during a
6-month period,11,24 with calculation of a 6-month oper-
ation rate for each surgeon to standardize the measurement
of CEA volume. Procedure volume was determined for
each hospital using the median number of CEAs performed
at any hospital to define high-volume or low-volume hos-
pital.25 Because the preoperative investigation of angiogra-
phy itself carries a significant risk of stroke,26 the number of
strokes resulting from this procedure before surgery also
was determined. Where both angiography and duplex scan
were performed, the level of carotid stenosis reported here
was on the basis of angiographic results.
Data validation. For validation of the number of
CEAs performed by each surgeon during the audit, we first
asked permission from the surgeons to contact hospitals in
which they performed CEA. Managers of medical records
departments then were contacted, and the total number of
first or only CEAs (with International Classification of
Diseases-10th revision-Clinical Modification procedure
code 33500-00) performed by each surgeon between spe-
cific dates was requested. Because we had collected only
deidentified data, matching individual patients was not
possible.
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RESULTS
Of 54 eligible surgeons, all agreed to participate (100%
consent rate). Most were vascular surgeons (n 47; 87%),
with five neurosurgeons (9%), one cardiothoracic surgeon
(2%), and one cardiovascular surgeon (2%). At the conclu-
sion of the audit, one participating vascular surgeon had
not performed any CEAs. Of the remaining 53, 52 pro-
vided data (98% response rate). Because most (n  33;
64%) provided data for longer than 6 months, the median
length of time of data collection per surgeon was 7 months
(range, 6 to 15 months). CEAs were performed at 46
hospitals: 24 public (52%) and 22 private (48%).
In total, Inpatient Audit Forms were received for 692
operations. Three patients underwent external CEA.
Twenty-three patients had two CEAs performed during the
study period. Of the 666 first or only procedures, 462
(69.4%) were performed on patients who were symptom-
atic and 204 (30.6%) were performed on patients who were
asymptomatic (Table I). The number of CEAs performed
by individual surgeons ranged from 1 to 39 (median, 10.5).
For 10 patients, the CEA had been performed by two
surgeons together, however. Patients from four surgeons
(n  45) in three hospitals had been reviewed by a neurol-
ogist after surgery.
Patient characteristics. Table I describes the charac-
teristics of 666 patients who underwent first or only CEA.
Thirty-day follow-up data were obtained for all of these
patients (100%). Most patients were male (67%), consistent
with international (NASCET: 69% male4; European Ca-
rotid Surgery Trial [ECST]: 72% male5) and local data
(68% male).27 The median age of patients was 72.6 years,
also consistent with NSW data (71.2 years).27 Two hun-
dred and eight patients underwent angiography before
CEA. Both angiography and duplex scanning were per-
formed for 187 patients, and 21 patients underwent only
angiography. A duplex scan only was performed before
surgery for 452 patients (data missing for six). Patients who
were asymptomatic were more likely to have a history of
cardiac disease (OR, 1.77; 95% CI, 1.25 to 2.50).
Thirty-day mortality rate. Eight deaths were docu-
mented for the 666 patients, six of whom had died as
inpatients. Thus, the all-cause 30-day death rate was 1.2%
(95% CI, 0.3% to 2.1%). Five of these deaths occurred in
patients who were symptomatic before surgery. The death
rate for patients who were symptomatic was 1.1% (95% CI,
0.0% to 2.2%). Because three deaths occurred in patients
who were asymptomatic before surgery, the death rate for
patients who were asymptomatic was 1.5% (95% CI, 0.0%
Table I. Patient characteristics by symptomatic type: First or only CEA (n  666)
Variable
Symptomatic
(n  462)
Asymptomatic
(n  204) Total (n  666)
1998/1999
NSW
Inpatient
statisticsn % n % n %
Gender
Male 307 66.5 140 68.6 447 67.1 67.8
Female 150 32.5 63 30.8 213 32.0 32.2
Missing 5 1.1 1 0.5 6 0.9
Age Group
 75 years 290 62.8 124 60.7 414 62.2 64.3
 75 years 161 34.8 67 32.8 228 34.2 35.7
Missing 11 2.4 13 6.4 24 3.6
Hospital Status
Public 353 76.4 160 78.4 513 77.0
Principal referral 286 81.0 121 75.6 407 79.3
Major metropolitan 30 8.5 24 15 54 10.5
Major nonmetropolitan 37 10.5 15 9.4 52 10.1
Private 109 23.6 44 21.8 153 23.0
No. of CEAs/ surgeon/ 6 months
6 CEAs (n  19) 58 12.6 19 9.3 77 11.6
6-14 CEAs (n  24) 234 50.6 104 51.0 338 50.8
15 CEAs (n  9) 170 36.8 81 39.7 251 37.7
Type of preoperative imaging*
Angiography only 15 3.2 6 2.9 21 3.2
Duplex scan only 299 64.7 153 75.0 452 67.9
Both angiography and duplex scan 144 31.2 43 21.1 187 28.1
Missing 4 0.9 2 1.0 6 0.9
Level of stenosis of operated artery
30% 2 0.4 1 0.5 3 0.5
49% 2 0.4 0 0 2 0.3
50%-59% 13 2.8 2 1.0 15 2.3
60%-79% 124 26.8 34 16.7 158 23.7
80%-99% 290 62.8 149 73.0 439 65.9
Occluded 1 0.2 0 0 1 0.2
Missing 30 6.5 18 8.8 48 7.2
*Percentages do not total to 100% because some patients underwent more than one test.
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to 3.1%). No significant difference was found between the
death rates for patients who were symptomatic and asymp-
tomatic (OR, 1.36; 95% CI, 0.32 to 5.73). Five of the eight
deaths (0.7%; 95% CI, 0.0% to 1.5%) were caused by stroke
(Table II).
Thirty-day fatal or nonfatal stroke rate. In total, 20
patients in the audit had a fatal or nonfatal stroke, resulting
in a 30-day fatal or nonfatal stroke rate of 3.0% (95% CI,
1.6% to 4.4%; ipsilateral stroke, 2.6%). Of the 462 patients
who were symptomatic, 14 had a fatal or nonfatal stroke
within 30 days of CEA (ie, 30-day fatal or nonfatal stroke
rate for patients who were symptomatic of 3.0%; 95% CI,
1.2% to 4.8%). Of the 204 patients who were asymptom-
atic, six had a fatal or nonfatal stroke within 30 days of
CEA. Thus, the 30-day fatal or nonfatal stroke rate for
patients who were asymptomatic was 2.9% (95% CI, 0.9%
to 5.0%). No significant difference was seen between the
30-day fatal or nonfatal stroke rates for patients who were
symptomatic and asymptomatic (OR, 0.97; 95% CI, 0.38
to 2.44). No patient had a stroke as a result of angiography
before surgery.
Thirty-day nonfatal stroke rate. In total, 15 patients
had a nonfatal stroke, resulting in a 30-day nonfatal stroke
rate of 2.3% (95% CI, 1.1% to 3.4%; ipsilateral stroke,
2.0%). Of the 462 patients who were symptomatic, 10 had
a nonfatal stroke within 30 days of CEA. The 30-day
nonfatal stroke rate for patients who were symptomatic was
2.2% (95% CI, 0.7% to 3.6%). Of the 204 patients who were
asymptomatic, five had a nonfatal stroke within 30 days of
CEA. The 30-day nonfatal stroke rate for patients who were
asymptomatic was 2.5% (95% CI, 0.4% to 4.5%). No signif-
icant difference was seen between the 30-day stroke rates
for patients who were symptomatic and asymptomatic
(OR, 1.14; 95% CI, 0.37 to 3.47).
Thirty-day stroke and mortality rate. There were
23 patients who either had a nonfatal or fatal stroke or who
died from a cause other than fatal stroke, resulting in a
30-day stroke and death rate of 3.5% (95% CI, 2.1% to
4.9%). Of the 462 patients who were symptomatic, 15 had
a nonfatal or fatal stroke or died from any other cause
within 30 days of CEA. The 30-day stroke and death rate
for patients who were symptomatic was 3.2% (95% CI, 1.5%
to 5.0%).
Of the 204 patients who were asymptomatic, eight had
a nonfatal or fatal stroke or died from any other cause within
30 days of CEA. The 30-day stroke and death rate for patients
who were asymptomatic was 3.9% (95% CI, 1.6% to 6.3%). No
significant difference was seen between the 30-day stroke and
death rates for patients who were symptomatic and asymp-
tomatic (OR, 1.22; 95% CI, 0.52 to 2.83).
Table II. Characteristics of eight patients who died within 30 days after CEA by symptom type: First or only CEA (n 
8)
Variable
Symptomatic
(n  5)
Asymptomatic
(n  3) Total (n  8)
n % n % n %
Gender
Male 3 60 2 67 5 63
Female 2 40 1 33 3 37
Age group
75 years 3 60 2 67 5 63
 75 years 2 40 1 33 3 37
Emergency operation
Yes 0 0 0 0 0 0
No 5 100 3 100 8 100
Side of CEA
Left 4 80 1 33 5 63
Right 1 20 2 67 3 37
Level of stenosis of operated artery
80% 0 0 0 0 0 0
80%-99% 3 60 3 100 6 75
Occluded 0 0 0 0 0 0
Missing 2 40 0 0 2 25
Cause of death
Stroke 4 80 1 33 5 63
Ischemic 3 75 1 100 4 80
Hemorrhagic 1 25 0 0 1 20
Ipsilateral to side of CEA 3 75 1 100 4 80
Contralateral to side of CEA 1 25 0 0 1 20
Brain stem stroke 1 20 0 0 1 12
Respiratory failure 0 0 1 33 1 12
Cardiac arrest after TURP 0 0 1 33 1 12
TURP, Transurethral prostatectomy.
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Table III compares the state (NSW) outcomes for
symptomatic patients with international benchmarks from
NASCET4 and ECST5 and for asymptomatic patients with
ACAS.6 Results from metaanalyses for both symptomatic8
and asymptomatic9 patients also are shown. Table IV sum-
marises intracluster correlations.
Side of stroke in relation to side of carotid endar-
terectomy. Of the 20 postoperative fatal or nonfatal
strokes, one was in the vertebrobasilar vascular territory
and the remaining 19 occurred in either the left or right
vascular territory. Of the 19 patients who had postoper-
ative stroke in either the left or right carotid territory, 17
patients had a stroke on the same side as the operated
carotid artery (ipsilateral stroke rate, 2.6%; 95% CI, 1.3%
to 3.8%) and two had a stroke in the opposite carotid
territory to the operated carotid artery. Of the 17 pa-
tients who had a stroke on the same side as the CEA
operation, four died. No significant difference was found
for the outcome of 30-day death between patients who
had a stroke on the same side as the CEA operation and
patients who had a stroke on the opposite side of the
CEA operation. No relationship was seen between symp-
tom status (symptomatic or asymptomatic) and whether
the postoperative stroke was on the same or opposite side
as the CEA operation.
Age, gender, and risk adjustment. No significant
differences were found in the four major outcomes when
compared with patient sex or age. Side of procedure also
was not significantly associated with any of the four out-
come measures. Fifty-one patients (7.7%) who underwent
CEA had an occluded contralateral artery. Patients who
had an occluded contralateral artery were more likely to
Table III. Comparison of NSW mortality and morbidity rates at 30 days after CEA by symptom status with prospective
studies
Study name Patient status before CEA
Surgical group 30-day
death rate
Surgical group 30-day
fatal or nonfatal
stroke rate
Surgical group combined
30-day stroke and
death rate
Current study
(n  666)
Symptomatic:
undergoing CEA in
NSW during 1999. All
level of stenosis
(n  462).
1.1%
(95% CI, 0.0%-2.2%)
3.0%
(95% CI, 1.2%-4.8%)
3.2%
(95% CI, 1.5%-5.0%)
ECST Collaborative
Group4
(n  3018)*
Symptomatic: all level of
stenosis. Group allocated
CEA (n  1807).
1.2%
(95% CI, 0.8%-1.8%)
6.4%
(95% CI, 5.3%-7.6%)
6.8
(95% CI, 5.6%-8.0%)
NASCET5
(n  659) *
Symptomatic: high-grade
carotid stenosis (70%-
99%). Group allocated
CEA (n  328).
0.6%
(95% CI, 0.1%- 2.2%)
5.5%
(95% CI, 3.3%- 8.5%)
5.8%
(95% CI, 3.5%-8.9%)
Meta analysis:
Cochrane Review9
(n  5841;
2 trials)
Symptomatic: all level of
stenosis. Group allocated
CEA (n  3181).
Not given Not given 2.8%
(95% CI, 2.2%-3.4%)
Current study
(n  666)
Asymptomatic:
undergoing CEA in
NSW during 1999. All
level of stenosis
(n  204).
1.5%
(95% CI, 0.0%-3.1%)
2.9%
(95% CI, 0.9%-5.0%)
3.9%
(95% CI, 1.6%-6.3%)
ACAS6 (n  1662)* Asymptomatic: 60%
carotid stenosis. Group
allocated CEA
(n  825).
0.4%
(95% CI, 0.1%-1.1%)
2.1%
(95% CI, 1.2%-3.3%)
2.3%
(95% CI, 1.3%-3.3%)
Meta analysis:
Cochrane Review10
Asymptomatic: group
allocated
Not given Not given 3.1%
(95% CI, 2.2%-4.4%)
(n  2203; 4 trials)* CEA (n  1087).
*Intention to treat.
Table IV. Intracluster correlations for four main audit outcomes
Outcome Rate 95% CI ICC Design Effect
30-day death 1.2% 0.3%-2.1% 0.016 1.192
30-day fatal or nonfatal stroke 3.0% 1.6%-4.4% 0.011 1.128
30-day nonfatal stroke 2.3% 1.1%-3.4% 0.004 0.955
30-day combined stroke and death 3.5% 2.1%-4.9% 0.003 0.966
ICC, Intracluster correlation.
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have stroke and death at 30 days (OR, 3.61; 95% CI, 1.36
to 9.56), fatal or nonfatal stroke (OR, 3.19; 95% CI, 1.09
to 9.32), and nonfatal stroke (OR, 4.67; 95% CI, 1.42 to
15.38).
No significant differences were found for the four out-
comes between patients who presented with hemispheric
transient ischemic attack (TIA) versus amaurosis fugax.
Patients with a history of TIA or stroke (n  258; 3.9%)
compared with ocular symptoms alone (n  107; 0.0%)
were significantly more likely to have a nonfatal stroke,
however (2  4.26; df  1; P .04). No significant
differences were seen in the four outcomes of death at 30
days, 30-day fatal or nonfatal stroke, 30-day nonfatal
stroke, and 30-day stroke and death when the known
vascular risk factor of diabetes was present or not present.
However, a significant linear relationship was found be-
tween patient preoperative hypertensive status and the out-
come of combined 30-day stroke and death (trend OR, 3.5;
95% CI, 1.6 to 7.7). Specifically, 0.5% of those patients
without preoperative hypertension (diastolic blood pres-
sure 90 mm Hg or systolic blood pressure 160 mm Hg
or both) had had a stroke or death at 30 days compared
with 4.2% of those patients with preoperative hypertension
on antihypertensive medications and 5.3% of those patients
with untreated preoperative hypertension.
Volume. No deaths were seen among the 77 patients
who underwent operation by surgeons (n  19) who
performed fewer than six CEAs per 6 months. However,
0.6% of the 338 patients who underwent operation by
surgeons who performed between six and 15 CEAs per 6
months (n  24) died, compared with 2.4% of the 251
patients who underwent operation by surgeons with a
volume rate of 15 or more CEAs per 6 months (n  9).
Poisson regression with the surgeon as the unit of analysis
suggested a higher incidence rate ratio among the high-
volume surgeons (incidence rate ratio, 4.96; 95% CI, 1.00
to 23.57), although the 95% CI includes one. Statistical
control for patient risk status also was not possible given the
small number of deaths.
Hospital characteristics. The number of CEAs per-
formed per hospital ranged from 1 to 86 (median, 9). No
significant differences were seen in the rates of 30-day
death, 30-day fatal or nonfatal stroke, 30-day nonfatal
stroke, or 30-day stroke and death for patients who under-
went operation at private, principal referral, major metro-
politan, or major nonmetropolitan hospitals. Nor were any
differences found in these outcomes for patients from low-
volume (10 CEAs; n  26 hospitals) or high-volume
hospitals (10 CEAs; n  20 hospitals). At the three
hospitals (one public, two private) where all patients (n 
45) had undergone physical examination 30 days after
surgery by a neurologist, significantly more 30-day fatal or
nonfatal strokes (OR, 5.05; 95% CI, 2.86 to 8.90), 30-day
nonfatal strokes (OR, 3.63; 95% CI, 1.08 to 12.13), and
30-day strokes or deaths (OR, 4.18; 95% CI, 2.58 to 6.80)
were seen.
Appropriateness. Four patients (0.6%; three symp-
tomatic, one asymptomatic) had CEA performed on a
carotid artery with 30% stenosis (n  2) or occlusion of
the carotid artery (n  1) outside recommendations of the
Australian guidelines2 (Table I). Insufficient statistical
power existed for detection of any differences between
these four patients and the rest of the sample.
Validation results. Fifty-one surgeons agreed to par-
ticipate in the validation study (98% response rate), most of
whom (63%) performed CEAs at two or more hospitals.
Information was received from all 46 hospitals (100%).
Participating surgeons reported a total of 700 CEAs, and
medical record departments from hospitals reported a total
of 741 CEAs. Table V summarizes the concordance be-
tween data provided by medical record departments and by
surgeons.
DISCUSSION
As in other Westernized nations, stroke imposes a heavy
burden of disease in Australia.1,2 It is important to assure
the public that surgical services achieve outcomes consis-
tent with best evidence. We conclude that NSW mortality
and morbidity rates for symptomatic patients are compara-
ble with those from NASCET,4 ECST,5 and the combined
metaanalysis.8 Furthermore, results for asymptomatic pa-
tients in our audit also are comparable with results of the
metaanalysis.9
Patients in our audit with a history of TIA or stroke
compared with ocular symptoms alone were significantly
more likely to have a stroke or death, however. In addition,
the benefit of controlling hypertension before surgery is
suggested by the significant decrease in stroke and death at
30 days for those patients taking antihypertensive medica-
tion, providing clear implications for better preoperative
management of this condition by surgeons.
Because of the low numbers of deaths, examination of
significant independent predictors of mortality was not
possible. This study also was not designed to compare
surgeon outcomes with each other. Indeed, with anticipa-
tion of an adverse event rate of 3%, outcome analysis by
individual surgeon would require between 15 and 47 years
of individual data collection.14
Some suggestion of a relationship between surgeon
volume and 30-day death rate was seen. This finding was, as
elsewhere,28-31 equivocal. A recent systematic review con-
cluded there was insufficient evidence to confirm that an
increase in volume necessarily results in better surgical
outcomes, however.32 We recommend additional empiric
work to explore plausible interactions in greater depth.
Table V. Concordance between data provided by
medical record departments and by surgeons (n  51)
Classification* n %
Number of surgeons who reported identical
number of CEAs as hospitals
11 22
Number of surgeons overreporting CEAs* 20 39
Number of surgeons underreporting CEAs* 20 39
*On basis of n  700 International Classification of Diseases–ninth revi-
sion–Clinical Modification codes.
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Our results also may have implications for implemen-
tation of CEA guidelines. Specifically, we found that four
patients (0.6%) had 30% stenosis (n  3) or an occluded
carotid artery (n  1) and underwent CEA contrary to
current guidelines.2 Uncertain imaging results before sur-
gery possibly may have accounted for the patient with
occlusion of the carotid artery undergoing surgery. In any
case, further research to explain practice outside guidelines
is recommended.
Two methodologic aspects of our audit deserve com-
ment. First, we could not provide resources to ensure that
all patients were assessed after surgery by a neurologist.
This may have resulted in underreporting of postoperative
stroke, consistent with our results showing poorer out-
comes for that subgroup of patients reviewed after surgery
by a neurologist.19 Future audits may well need to ensure
independent outcome assessment for all cases.
Second, the discrepancy between the hospital tally and
the surgeon tally may reflect surgeon reporting bias. NSW
1998/1999 inpatient data suggest our sample was repre-
sentative in terms of age and sex, however.27 That medical
record departments had no record of some cases submitted
by surgeons also was inexplicable.
In summary, we achieved high levels of cooperation
from surgeons, in an ambitious state-wide surgical audit.
That audit data forms had been developed through consen-
sus over an extensive 18-month period before embarkment
on prospective data collection was crucial. Our audit con-
firms that outcomes comparable with those documented in
randomized trials can be achieved in NSW even with less
rigorous patient, hospital, and surgeon selection criteria.
We thank all surgeons who participated and our 12
external protocol reviewers.
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Appendix. Members of NSW CEA audit PWG
Dr Nigel Ackroyd, A/Prof Michael Appleberg,* Dr
Roy Beran, A/Prof Michael Besser, Dr Jeff Blackie, Dr
Bernard Bourke, Dr Keith Burton, Dr Jennifer Chambers,
Dr Glenn Close, Dr Geoffrey Coffey, Dr Alastair Corbett,
Dr Helen Creasey, Dr John Crozier, Dr Joe Enis, Dr Eric
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Farmer, Dr Charles Fisher, Prof John Fletcher, Prof John
Frawley, Dr Alan Gale, Dr Stuart Gamble, Dr Raymond
Garrick, Mr Richard Gilbert, Dr Anthony Grabs, Dr John
Graham, Dr Lawrence Gray (deceased), Dr Anthony Gray-
Weale, Dr Kevin Hanel, Prof John Harris,* Dr Stuart
Hazelton, A/Prof Adrian Hibberd, Mr Richard Hicks AO
(deceased), Dr Kim Hill, Dr David Horton, Dr David
Huber, Dr Robert Johnston, Dr Rod Lane, Dr Chris Levi,
Dr Eric Lippey, Prof Reginald Lord, Prof Robert Lusby,
Prof James May, Dr Alan Meek, Ms Sandy Middleton, Prof
Michael Morgan, Dr John Niesche, Dr Marjorie Pawsey,
Dr Adam Rapaport, Dr Philip Robinson, Dr David Rosen,
Dr David Sharpe, Dr Warwick Stening, Dr Michael Ste-
phen, Dr David Stevenson, A/Prof Peter Thursby, Dr
Peter Tomlinson, Prof Jeanette Ward,* A/Prof Geoff
White, Dr Scott Whyte.
*Secured funding for study.
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